Murdoch Children's Research Institute, Parkville, Victoria, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
Allergy. 2019 Jun;74(6):1063-1080. doi: 10.1111/all.13732. Epub 2019 Mar 6.
Despite an increasing number of publications from individual countries and regions, there is still no systematic review of the global epidemiology of anaphylaxis in the general paediatric population.
We conducted a systematic review, using a protocol registered and published with the international prospective register of systematic reviews (PROSPERO). Results were reported following PRISMA guidelines. The search strategy was designed in Medline (ovid) and modified for Embase (ovid) and PubMed. Papers were screened by two independent reviewers following selection and exclusion criteria. Data extraction and risk of bias assessment were completed by the same two reviewers. Studies in adults only or those that did not report data in children separately were excluded.
A final total of 59 articles were included. Of these, 5 reported cumulative incidence, 39 reported incidence rate and 17 reported prevalence data. The incidence of anaphylaxis in children worldwide varied widely, ranging from 1 to 761 per 100 000 person-years for total anaphylaxis and 1 to 77 per 100 000 person-years for food-induced anaphylaxis. The definition of anaphylaxis from NIAID/FAAN was the most commonly used. Gender and ethnicity were demographic risk factors associated with anaphylaxis in children. Increasing total or food-induced anaphylaxis incidence over time was reported by 19 studies.
The reported incidence of anaphylaxis in children varied widely. Studies in developing countries are underrepresented. To accurately compare anaphylaxis incidence between countries and investigate the time trends, further studies using a standardized definition across different countries are required.
尽管来自个别国家和地区的出版物越来越多,但目前仍缺乏对普通儿科人群中过敏反应全球流行病学的系统评价。
我们按照国际前瞻性系统评价注册平台(PROSPERO)的方案进行了系统评价。结果按照 PRISMA 指南进行报告。检索策略在 Medline(ovid)中设计,并针对 Embase(ovid)和 PubMed 进行了修改。根据选择和排除标准,由两名独立评审员对论文进行筛选。数据提取和偏倚风险评估由同两名评审员完成。仅包含成人的研究或未分别报告儿童数据的研究被排除在外。
最终共有 59 篇文章被纳入。其中,5 篇报告了累积发病率,39 篇报告了发病率,17 篇报告了患病率数据。全球儿童过敏反应的发病率差异很大,总过敏反应的发病率范围为每 100000 人年 1 至 761 例,食物诱导过敏反应的发病率为每 100000 人年 1 至 77 例。NIAID/FAAN 制定的过敏反应定义是最常用的。性别和种族是儿童过敏反应的人口统计学危险因素。19 项研究报告了过敏反应的发病率随时间增加。
报告的儿童过敏反应发病率差异很大。发展中国家的研究代表性不足。为了准确比较不同国家的过敏反应发病率并研究时间趋势,需要在不同国家使用标准化定义进行进一步的研究。